Hospital at home and early discharge schemes for patients experiencing an acute exacerbation of their chronic obstructive pulmonary disease, appear to be an effective and safe option for selected patients and these services have become increasingly common. Here we discuss the evaluation of such schemes including: the rationale for evaluation; aspects of quality which might be considered for evaluation; the role of evaluation frameworks, quantitative and qualitative evaluation and steps in planning an evaluation. Chronic Respiratory Disease 2007; 4: [33] [34] [35] [36] [37] [38] [39] [40] [41][42][43] 
Introduction
Hospital at home and early discharge (HaH/ED) schemes for patients experiencing an acute exacerbation of their chronic obstructive pulmonary disease (COPD) have become common. Forty-four percent of the units responding to the 2003 UK national COPD audit had some form of hospital at home or early discharge scheme. 1 A recent Cochrane systematic review concluded that: 'Hospital at home schemes for patients with acute exacerbations of COPD can be used as an alternative to hospital admission and are an effective and safe option for suitable patients'. 2 Another systematic review, which included studies with non-randomized controlled designs, reached similar conclusions. 3 However, both reviews identified the need for further studies in this area.
HaH/ED schemes for acute exacerbations of COPD are 'complex interventions' made up of several different interconnecting components 4 and may differ considerably from those described in the published literature. A recent survey in England and Wales identified a large number of schemes offering both care for patients with an acute exacerbation and ongoing chronic disease management. 5 We are not aware of any peer reviewed, published evaluations of such 'hybrid' schemes.
Drawing on our experience of evaluating health services and the extended literature review, 3 this paper discusses the evaluation of HaH/ED services for COPD. It is principally directed at clinicians and managers who may be considering evaluating their own services. It would be impossible to cover every aspect of evaluation here but we aim to raise some important points for consideration when planning an evaluation this sort of service. Economic evaluation and research governance are beyond the scope of this article.
Why evaluate?
Health service evaluation has been defined as: 'The critical assessment, on as objective a basis as possible, of the degree to which entire services, or their component parts (eg, diagnostic tests, treatments, caring procedures) fulfil stated goals'. 6 Thus evaluation covers a spectrum from 'local' evaluation projects (which may overlap with audit) that provide information about a particular service, to original research projects with results which may be generalized across services and contribute to the scientific evidence base. A properly conducted evaluation can consume considerable resources so the first question to consider when contemplating an evaluation is perhaps: 'why evaluate?'
REVIEW SERIES: Hospital-at-home for COPD
Evaluating hospital at home and early discharge schemes for patients with an acute exacerbation of COPD Possible reasons for conducting an evaluation include: 1) Evaluation can provide feedback and reassurance to staff, users and carers -all of whom have an interest in knowing the service is functioning as intended, meeting its aims and objectives, and is without any adverse effects. 2) Evaluation can be used to inform programme planning and may lead to improvements in service delivery (eg, by suggesting the optimal hours for a service to run). 3) Evaluation may be necessary in order to justify the continued funding of a service. (In England and Wales in 2003 nearly one quarter of all of HaH/ED services involving specialist respiratory nurses were funded, at least in part, by non-recurrent monies.) 5 
4) Evaluation may be a vehicle for disseminating
information about a new service or a description of a new model of care. 5) Alternatively, evaluation may address an original research question -this could concern an aspect of home care for patients with acute exacerbations of COPD not studied previously. There remain a number of unanswered research questions around HaH/ED schemes for COPD. 2, 3 Whatever the reason for the evaluation, the definition proposed above means it is only possible if the intended aims of the service being evaluated are clear to the evaluators.
What to evaluate?
In addition to the necessity of identifying the aims of the service to be evaluated, all evaluations need a clear research question or clear aims and objectives. Before the aims and objectives of the evaluation can be determined, it is necessary to decide what aspects of the service are to be evaluated. Evaluation typically focuses on clinical outcomes and health service resource use but there are other important aspects which can be evaluated. Maxwell proposed six dimensions of quality in health care which are often quoted when considering evaluation: accessibility, appropriateness, equity (or 'fairness'), social acceptability, effectiveness and efficiency (often translated as costeffectiveness). 7 Smith and colleagues have described four dimensions for health care evaluation: effectiveness ('the extent to which an intervention produces a beneficial result under usual conditions of clinical care'), efficiency, humanity ('the social, psychological and ethical acceptability of the treatment that people receive from health care'), and equity ('equality of opportunity, provision, use or outcome'). 8 In Table 1 we consider how Smith's dimensions might be applied to a HaH/ED scheme. In practice it is probably never feasible to evaluate every single aspect of a service and the nature of an evaluation is dictated by its aims and the resources available to do it. In addition it may be very helpful to consider a framework for the evaluation, particularly if more than one aspect or component of a service is to be evaluated. Frameworks are helpful for structuring an evaluation to ensure recognized, generalizable dimensions of quality are used. This can allow for comparison with similar services or with similarly evaluated but different services. The dimensions of quality described above might be used as a framework for evaluation, but there are other quality evaluation frameworks; perhaps the commonest is Donabedian's structure, process and outcome framework, originally described in 1966. 9 An explanation and examples of how this model might be applied to HaH/ED schemes are given in Table 2 .
Evaluation which pays particular attention to the implementation of a service is known as process evaluation. This type of evaluation is particularly important in local evaluations where outcome data are difficult to obtain, or where there is good evidence of effectiveness from published trials, but where it is necessary to • Dose received. The extent to which recipients take up and engage with different aspects of the intervention (eg, the proportion of patients in an ED scheme who participate in the pulmonary rehabilitation component).
• Fidelity. The extent to which the intervention was delivered as planned (eg, are patients being visited at home within 24 hours of discharge?).
However it should be borne in mind that, by its very nature, this process evaluation framework does not consider the costs or effectiveness of an intervention. The choice of framework can be dependent on the background or discipline of the evaluator and it is often wise to test a proposed framework with the commissioner of the evaluation to check that the desired dimensions of quality assessment are included. Once the aims, resources and framework for the evaluation have been identified it is necessary to decide how the aims will be met, in other words to determine the objectives of the evaluation. In many cases the aims can be addressed with both quantitative and qualitative methods.
What sort of evaluation?

Quantitative evaluation
Quantitative evaluation is traditionally divided into experimental designs [randomized controlled trials (RCTs)], and quasi-experimental or observational designs. In local evaluations it is rarely feasible to randomise patients or units to different types of care, so the latter are more common. Table 3 summarizes some aspects of different designs with reference to evaluating HaH/ED schemes and gives examples of published evaluations.
Routine data
Many observational evaluations will rely on the small, ad hoc administrative databases which are almost invariably established alongside the HaH/ED scheme and these can be a powerful source of evaluative process data, potentially offering the opportunity for evaluation to be built into the scheme from the beginning. Features which increase the likelihood of high quality administrative data may include: 1) a welldesigned data base with clearly defined variables, 2) provision of adequate resources (eg, staff time) to enter data regularly, ideally around the time it is collected, 3) staff who enter the data understanding its value, and 4) regular use of the data. Typical problems encountered using an administrative data base in the evaluation of an early discharge service include incomplete records and inconsistent data entry.
Other routine data are principally collected for financial purposes and are generally activity based rather than patient based. Since it can be problematic Before and after studies Involve comparing outcomes of interest (eg, length of hospital stay) before and after the service under study is implemented.
Retrospective cohort studies
Studies of events which have already occurred and where the data used has already been documented, possibly within some routine information system.
Cross-sectional surveys
A representative sample of the population of interest (eg, carers, patients or staff), or indeed the entire population of interest, is surveyed. May involve questionnaires or telephone, or face to face, interviews.
• Sit at the top of the 'hierarchy of evidence' (just below metaanalysis of SRs RCTs) and considered by many to be the 'gold standard' in effectiveness evaluation in health care. • Random allocation means potential sources of bias (confounders) that evaluators are aware of, together with all the unknown potential confounders, are likely to be evenly distributed between the two arms of the study and therefore unlikely to influence the outcome. • There are widely accepted guidelines on the proper conduct and reporting of RCTs. 35 • May be useful when an RCT is not possible. • Prospective comparison groups minimise the likelihood of coincidental temporal effects, such as major health service reorganisation or trust mergers, influencing results.
• Usually less expensive than an RCT. • No need to find a separate comparison group.
• May be less expensive than other forms of quantitative evaluation because the data has already been collected (but see commentary on routine data). • Prospective data collection may be added to increase the time of follow-up.
• May be an efficient way of eliciting specific information. • Relatively inexpensive (but data entry requires resources).
• Expensive and difficult to conduct well, RCTs are only done as part of a formal research project. • The strict eligibility criteria employed in most RCTs of HaH/EDs may have made their results less generalisable to the population of patients with and acute exacerbation of COPD as a whole. • In HaH/ED scheme trials sample sizes large enough to demonstrate statistically significant differences in outcomes (eg, deaths) may be too large to be feasible.
• It may be difficult to recruit patients (or units) in the comparison group to participate in the study. • Subject to bias (systematic error) and confounding. • Unlikely to be much less expensive than an RCT. • May be impossible to blind outcome assessors.
• Subject to bias (systematic error) and confounding, especially if retrospective 'before' data is collected. • New HaH/EDs tend to run very differently early on to the way they run when they are well established -collecting the 'after' data too early may lead to misleading results. • Contemporaneous changes in the overall organisation of health services (eg, in the UK the introduction of 'Payment by Results') may make the results of the study difficult to interpret. to reconstruct an individual patient's experience from such data they may be difficult to use for evaluation. Problems we have recently encountered using routinely collected hospital activity data to evaluate an early discharge service are described in Box 1.
approximately half these deaths occurring during the index admission. 1 Patients who are eligible for HaH/ED schemes are likely to have much lower 90 day mortality rates (reported rates vary from 2.4% to 9% 3 ). Although many RCTs of HaH/ED schemes have reported mortality none has been large enough to be able to determine whether or not mortality is influenced by these schemes [if the expected 90 day mortality is 9% in order to detect a 50% reduction or increase in deaths a RCT would need more than 1000 patients (90% power at the 0.05 significance level)]. Thus for most evaluations mortality will be an uninformative outcome.
Lengths of stay
Since HaH/ED schemes involve a reduction in hospital use evaluators might be interested in the actual length of stay (LOS) for in patients admitted with COPD. In practice there is considerable variability between hospitals in LOS following an admission for COPD, in the UK national audit the median LOS was seven days (inter-quartile range, IQR four to 11 days) in hospitals without access to a HaH/ED scheme and in hospitals with access to a scheme the median LOS was six days (IQR three to 10 days) (M Roberts: personal communication). If some or all patients in the HaH/ED scheme avoid admission altogether then, paradoxically, LOS could be increased since those admitted are likely to be sicker than those in the scheme (although this does not appear to be the explanation for the modest differences in LOS with access to an ED scheme seen in the UK national audit since only four out of 8013 episodes involved admission prevention). All this suggests that observational evaluations which measure LOS using retrospective studies of routine data may see only modest effects. These studies are also difficult to interpret because of unrelated influences on LOS eg, closure of wards because of methicillin resistant Staphylococcus aureus. LOS in patients admitted to a HaH/ED scheme is a useful process indicator.
Readmission to acute care
Re-admission to acute care is one of the most commonly reported outcomes in evaluations of both HaH/ED schemes and chronic disease management programmes in general. It is important to be clear which time period is being considered, the two most commonly considered time frames are readmissions at two weeks and 90 days. Readmission within two weeks of entry into a HaH/ED scheme is commonly assumed to arise from the original acute exacerbation rather than a new exacerbation. In published evaluations 7-11% of patients entering a HaH/ED scheme are admitted before they are discharged from the 2) Lack of timeliness -prolonged administrative processes mean that these data are often six months old. 3) Lack of accuracy -presumably caused by keying errors (eg, we found a person with four different entries in the gender column, and people with a negative age arising from a date of birth in the late 2000s). 4) Missing data (eg, we found very poorly recorded ethnicity data). 5) Problems with ethical approval and the anonymization of routine data. We did not have access to the names of patients in our study and had to use birthdate, gender and postcode to identify an individual -if any of these were missing or misentered there were problems. In order to identify a readmission we needed to make a person-based record -but if coding errors occurred -eg, if a person's birth date was misentered -or they were readmitted from a different postcode it could be impossible to work out whether this was two people or one. 6) Lack of other information. We wanted to know about comorbidity but information can be poorly entered for this -eg, a codiagnosis of diabetes may not always be mentioned for someone who has an admission for COPD. Also we had no routine measure of the severity of the condition.
Outcomes and endpoints
Outcomes in evaluation can be defined as all the possible results, including identified changes in health status, which may stem from a therapeutic intervention. 11 The choice of outcome obviously depends on the aims and objectives of the evaluation. Various published evaluations of HaH/ED schemes have examined the following outcomes: 3 health related quality of life (see below), patient satisfaction with the service and preference for HaH/ED schemes or usual care, patient knowledge about COPD and self-management skills, carer satisfaction and service preferences, deaths at three months, pulmonary function, arterial oxygen saturation, symptoms, days spent in hospital at initial presentation, days under the HaH/Ed scheme, readmission before discharge from the scheme, hospital readmission within three months; attendance at A&E within three months, provision of social services, home visits by the general practitioner, and general practitioner satisfaction with the service.
Mortality
Overall, the mortality associated with an acute admission for COPD is high -in the UK national audit 15% of those admitted were dead within 90 days with scheme, ie, usually within two weeks. [12] [13] [14] Since the published studies often involve a selective population of COPD patients this proportion might be higher as these schemes are rolled out more widely (alternatively it might fall as clinicians and patients gain more experience of HaH/ED schemes).
Overall, readmission at 90 days amongst patients who have been admitted with COPD is very high-31% in the national audit, 1 and there is no evidence that readmission is affected by HaH/EDs in the published evaluations. 2 However, some HaH/ED schemes, particularly those we have described as 'hybrid' schemes, may aim to reduce subsequent acute admissions for acute exacerbations. If evaluators are interested in looking at admissions following involvement with a HaH/ED scheme it is imperative that they distinguish planned from unplanned admissions, 15 since increased elective admissions might indicate higher quality care or patients whose baseline health has improved to such an extent that they have become fit enough to undergo an elective procedure. In addition, since patients with COPD are elderly and have substantial comorbidity 16 evaluators may also be interested in distinguishing respiratory admissions from other types of acute admissions. It is worth considering carefully how the cause of a readmission is determined. In a RCT the ideal way to determine cause of admission is to examine patients' notes by an expert endpoint committee, whose members are unaware of the group to which each patient has been allocated. Alternatively, a single blinded assessor may be used with a random sample of notes being rechecked by a blinded committee for validation. If possible the same methods should be adopted in non-experimental studies. (In practice even published studies on readmission for chronic conditions rarely describe how the cause of admission was identified.) Patients may also be readmitted to other hospitals -ignoring these admissions may lead to erroneous conclusions but it is likely to be much more difficult to get high quality data on the cause of these admissions. Finally when considering readmissions, evaluations may lack the statistical power to detect small differences, eg, Davies calculated that an RCT would need over 3000 patients to detect a 5% difference in readmission rates. 13 
Health related quality of life
Some outcomes, such as quality of life (defined below), can not be measured by direct observation and are rarely collected as a routine. Outcomes like these could be explored using qualitative methods but are commonly assessed using questionnaires often referred to as 'instruments'. Features to consider when selecting an appropriate instrument include its reliability (how consistent and repeatable the measure is and its sensitivity to change) and its validity -the extent to which the instrument measures what we think it is measuring. There are several different aspects of validity; these include 'face' and 'content' validity which reflect whether the separate items in an instrument appear to cover all the relevant areas of interest. 17 Since developing and validating a new instrument is difficult and extremely time consuming, evaluators are advised to use existing, validated instruments. The American Thoracic Society website has a useful section describing all the disease specific and generic instruments that might be used with respiratory patients. It should be noted that the instrument may no longer be valid or reliable if it is not administered in the recommended way or if questionnaire items are changed or omitted (this includes the administration of a subscale rather than the whole instrument unless the subscale has been independently validated). It is important to appreciate what difference in score is clinically important. Published evaluations often report statistically significant differences in disease measures, or components or subscales of instruments, which are of dubious clinical significance. Finally, however good the instrument used the quality (and value) of the resulting data will be influenced by the way respondents are recruited and by the response rate.
There is no universally accepted definition of quality of life but Bowling has described it as; 17 'A concept representing individual responses to the physical, mental and social effects of illness on daily living which influence the extent to which personal satisfaction with life circumstances can be achieved. It encompasses more than adequate physical well-being, it includes perceptions of well-being, a basic level of satisfaction and a general sense of self-worth. ' Quality of life is an important outcome in a chronic, progressive condition like COPD. The disease may also have a huge impact on the quality of life of patients' carers. 18 The impact of hospital at home and early discharge schemes on patients' and carers' quality of life has been little studied. 3 Instruments to measure health related quality of life (HRQOL) in patients may be disease specific or generic. There are pros and cons to both types of measure -generic measures (eg, Short Form 36), SF-36 19 allow comparison with patients with different conditions (eg, lung cancer and COPD) and some can be used in economic evaluations to generate costs per quality adjusted life year. However they may lack the sensitivity to detect clinically important differences in HRQOL in some patients with specific symptoms, or in patients who are particularly ill or well (they may also exhibit 'floor' and 'ceiling' effects -everybody scores Evaluating early discharge schemes for COPD S Taylor et al.
minimally or maximally). Disease specific HRQOL measures tend to be more sensitive to change (although they may also exhibit floor and ceiling effects) and may have the advantage of appearing more relevant and meaningful to patients. Evaluations often use a combination of disease specific and generic HRQOL measures although it is obviously important not to overburden patients. The most commonly used disease specific HRQOL instrument in COPD is the St George's Respiratory Questionnaire (SGRQ). 20 This 'supervised self-complete questionnaire' 21 has about 50 individually weighted items which are combined to give a total score out of 100. The questionnaire items cover three domains: symptoms, ability to conduct physical activities, and the impact of the disease on the patient's life. Several studies have found that a four-point change in the total score is suggestive of a clinically important difference. 22 Ståhl and colleagues examined the ease of completion of the SF-36 and SGRQ in 174 Swedish patients with COPD-around a tenth found them difficult or very difficult to complete. 23 
Patient and carer satisfaction
Patient and carer satisfaction would appear to be a very important outcome (or process measure) for HaH/ED schemes yet there are surprisingly few published studies which report this and we are not aware of any validated instruments for determining patient satisfaction with HaH/ED schemes. In one RCT, unvalidated questionnaires were used, but the study was too small to provide robust evidence about differences between the HaH and inpatient schemes that were being compared. 24 In practice, using questionnaires to measure patient satisfaction is difficult -patients' responses are heavily influenced by the framing of questions and how they are asked 25 and by the patients' own expectations and beliefs. 26 Because of these difficulties The Picker Institute Europe (www.pickereurope.org/ index.php) advocate questionnaires to capture patient experience rather than satisfaction. Their inpatient surveys distinguish eight dimensions of patient-centred care which might be adapted for evaluating a HaH/ED scheme (see Box 2) . It may be very helpful to work with patient or carer groups to develop the content and wording of questionnaires. 27 
Sample size and analysis of quantitative data
Whatever outcome data are collected the exercise will be uninformative if it is analysed inappropriately or if the sample size is inadequate. Both analysis and sample size requirements depend on the type of evaluation and the type of outcome. The principle of all analyses should be to provide appropriate summaries of appropriate outcomes and, where HaH/ED is being compared with standard hospital admission, to make a valid comparison between the two groups using an appropriate outcome. The outcomes discussed above require different forms of summary. For LOS a summary measure might be the mean length of stay or the median length of stay, eg, Sala showed that the mean length of stay in a group of patients given supported discharge was 5.9 days compared to eight days for a group given usual hospital care. 28 Length of stay can also be usefully summarized using graphs. The most commonly used is the Kaplan-Meier (K-M) survival curve, 29 where survival here equates to remaining in hospital, and death to discharge from hospital. K-M curves show how the chance of remaining in hospital decreases over time.
(We could not find any published examples of evaluations of HaH/ED schemes that displayed K-M curves.) In considering readmission, investigators may summarize the data using the proportion of individuals readmitted in a given time, the rate of readmissions per patient in a given time, or time to readmission. Time to readmission can be summarized in the same way as length of stay in hospital. For example, Skwarska presents median time to readmission for a group on a HaH scheme (seven days) and a group given usual hospital care (five days); they also report that 25% of the home supported group and 34% of the admitted group were readmitted within eight weeks. 14 Quality of life and patient satisfaction are usually measured as scores, and mean score may be an appropriate summary measure, although this depends on the scoring system for the instruments being used. For the patient satisfaction instrument used by Ojoo and referred to in the previous section, the summary measures were proportions satisfied (88% in the conventional care and 92% in the HaH group). 24 When two different types of care are being compared evaluators are advised to seek advice from a statistician about suitable analyses, since there are many, and they depend on the type of outcome and the question being asked. In the Skwarska study, the difference in time to readmission appeared to reflect a real difference that would be likely to be seen in similar patients whereas the difference in proportions readmitted appeared to be due to chance. 14 In addition, whichever outcome and summary measure is being used, the sample of individuals on which data are collected needs to be large enough to ensure that any summary measures and comparisons can be calculated with sufficient precision. Calculations can identify the size of the sample required but rely on investigators making some decisions in advance about how precise they wish their results to be or what they would regard as an important difference between groups being compared. Again, investigators are strongly advised to consult a statistician for advice on how large their sample needs to be.
One issue that arises in reporting outcomes from evaluations in which patients tend to be elderly, and/or suffer from substantial comorbidity, is reporting those who die or who are readmitted for reasons other than that which is of primary concern. This is an issue because those who die or are admitted to hospital cannot then be admitted for the reason of primary concern. When this happens, investigators should make sure they report all the relevant information so that those reading the evaluation have the whole story and not just a part of it.
This issue of how to deal with patients who experience outcomes other than the one of primary interest, particularly when this affects the chance of experiencing the main outcome, is more acute in evaluations involving comparisons. This is largely because these other outcomes may be experienced differentially between the two groups and any comparison which does not take this into account may then be biased; it is crucial therefore, that investigators report full information on all relevant outcomes and their sequence to ensure that readers can make a full assessment of possible biases.
A second issue arises in the interpretation of results from evaluations comparing HaH schemes and standard hospital admission. Ideally investigators would like to say that any differences found in outcomes are due to the different schemes, but this assumes patients involved in the two schemes are comparable. For example, in the evaluation by Sala (see Table 2 for details) it is possible that patients who lived in the city differed in some way from those who lived outside, and that differences in outcome between the two groups are partly a result of this and not due to the different schemes. 28 Randomized controlled trials avoid this confounding (Table 2) .
Qualitative evaluation
Qualitative research; 'Helps us to understand social phenomena in natural (rather than experimental) settings, giving due emphasis to the meanings, experiences, and views of all the participants'. 30 Qualitative research may be used to generate theories (which might be tested quantitatively), to develop and refine interventions (which might then be evaluated) and to help confirm or explain quantitative findings. A brief description of some qualitative methods which might be applied to the evaluation of HaH/ ED services, together with their advantages and disadvantages, is outlined in Table 4 .
Sampling for qualitative research tends to be purposive (ie, subjects are deliberately chosen). Various sampling strategies have been identified 31 in evaluation of HaH/ED schemes including: maximum variety sampling (purposefully picking a wide range of variation in areas of interest eg, patients who live alone, patients who live with a spousal carer, patients who live with adult children), typical case sampling, deviant case sampling (learning from extreme or unusual cases eg, patient who has a spell in intensive care) and combination or mixed sampling (a flexible approach which encourages triangulation, this may combine the above and other approaches).
As Table 4 suggests, collecting qualitative data may require considerable resources and analysing qualitative data may be very labour intensive and can be a real problem for unsupported, inexperienced evaluators. Qualitative data are analysed systematically, generally field notes and transcripts of recorded data are read several times in order to identify potential categories or themes and the data is catalogued under these themes. 32 The identification of potential themes for analysis usually commences whilst the data are being collected in the field. Indeed, as the research progresses it is permissible to change and adapt interview and focus group prompts to explore emerging themes in more detail.
Evaluators are strongly advised to seek expert help when designing or analysing qualitative evaluations. Qualitative research methods arise from social science theory and much has been written about the limitations of analysing this type of data from a theoretical perspective; 'To treat what people say and do as self-evident, without a theoretical framework in which to interpret facts or descriptions, reduces the power of subsequent qualitative analysis to little more than accumulated accounts of common sense. In turn this simply leads to the discrete accumulation of empirical data -thus stultifying the development of theoretical insights, however limited. Qualitative analysis should extend beyond ordering the content of individual's responses and narratives along identified themes. The question becomes not simply what pattern can be discerned from people's narratives, but also, why this pattern and not others?' 33 In pragmatic local evaluations qualitative data may be usefully analysed without reference to underlying theory but evaluators are likely to gain even more from a study if they analyse their data from a theoretical perspective. For example, a qualitative study of patient self-management in a HaH/ED scheme setting might identify some deficiencies in the scheme. If the same data were analysed in light of, for example, Lorig's work on self-management education 34 why the deficiencies might have arisen and how they could be addressed may be better understood.
How should an evaluation be done?
Participatory approach
When planning an evaluation it is very important to adopt a participatory approach. Staff providing the service need to be consulted and involved from the start for at least three reasons: 1) their cooperation is a requirement of a good evaluation, 2) they may offer valuable suggestions regarding the evaluation and its design, 3) they may well feel threatened and undermined if the are not consulted. The involvement of service Table 4 Qualitative methods for the evaluation of hospital at home/early discharge schemes
Method and description Advantages Disadvantages
Non-participant observation The researcher systematically watches, listens and records events (using a tape recorder, video recorder or by making notes) to find out about behaviours and events in their natural settings. 32 eg, the researcher may observe a home visit.
Person to person interviews
The researcher interviews study subjects and records the interviews as above. Interviews may be unstructured and in-depth or, more commonly, semi-structured where the interviewer asks open ended questions and allows the interviewee to talk freely but also uses a 'topic guide' (or list of prompts) to ensure that all areas of potential interest to the study are covered. Because they are labour intensive to conduct and analyse typically only a small number of interviews will be conducted.
Focus groups
'Semistructured, person-to-group interviews that aim to explore a specific set of issues" 38 which capitalize on group interaction to generate data. Often used to elicit users' and/or carers' opinions about a service. Groups usually involve four to 12 participants with a researcher acting as a facilitator and preexisting groups may be used. The sessions are usually recorded with a second researcher making notes on which participant is speaking and on any non-verbal communication.
Most studies use just a few focus groups.
Descriptive case studies 'These focus on a single instance or very small number of instances for in-depth scrutiny'. 37 These 'cases' (here usually individual patients, carers or members of staff) may be selected randomly or purposively. Data may be collected retrospectively or prospectively and may include observational data, interviews and documentary analysis.
• Findings not constrained by preconceptions.
• Powerful way of recording events as they actually happen, may overcome the discrepancy between what people say they do and what they actually do. • May provide a very rich source of data.
• Highly effective way of eliciting information on the areas of interest. • Provides opportunity to explore responses. • Flexible -if analysis is iterative the topic guide can be developed to explore areas arising from other interviewees (or from quantitative work).
• The group process may stimulate discussion.
• Useful way of eliciting information from several people, less time consuming than the equivalent number of one to one interviews. • Can encourage contributions from people who are reluctant to be interviewed one-toone or who feel they have 'nothing to say'. 39 • Flexible -if analysis is iterative the topic guide can be developed to explore areas arising from other interviewees (or from quantitative work). • Differences in views and experiences can be explored in situ with the help of the research participants.' 39 • Useful at an early, exploratory phase. 37 • May help identify issues to be studied in more depth.
• Presence of the observer may influence events. • The observer may be subject to bias. • May be time consuming.
• Analysis of the data collected may be difficult and time consuming.
• Sampling strategy essential (see text).
• The interviewer should be aware of how she/he may be influencing the interview. • The interviewer may unconsciously direct responses. • Ideally the interviewer should be experienced in this type of research. • May be time consuming.
• Being in a group may influence the responses of participants. • May not be possible to explore areas in detail or to follow up interesting comments. • Ideally, the facilitator needs to be experienced in running focus groups.
• At risk of becoming 'merely an extended anecdote without evaluative relevance'. 40 providers in the design of a properly conducted evaluation should enhance its value rather than compromise its findings. This participatory approach should extend to the involvement of some service users and carers in evaluations. Useful information about involving patients and carers can be found on the INVOLVE website (www.invo.org.uk).
Ethical approval and dissemination of results
Most evaluations (apart from a straightforward audit) will probably require ethics committee approval. A useful rule of thumb is that if anything is being done to patients or carers that would not usually be done to them (eg, involvement in focus groups, interviews) the evaluation will have to gain local ethics committee (LREC) approval and publication of findings in a journal will almost inevitably need ethics approval for this sort of evaluation. Evaluators are advised to consult their LRECs and trust research and development offices (as applicable) for advice. Naturally, evaluation is only useful if something is done with the findings. Therefore it is important to consider at an early stage, how to disseminate the results and again, this may well require resources. Evaluators should also consider how they will disseminate their finding back to the patients, carers and staff who were actually involved in the evaluation. It is useful to ask interviewees how they would like to receive feedback at the time they are interviewed.
Steps in an evaluation
To summarize, an evaluation of a HaH/ ED scheme should involve the following steps: 1) Identify the reasons for the evaluation. 2) Identify the resources available for the evaluation (ie, people's time, funding). 3) Become familiar with the published literature relevant to your evaluation. 4) Establish a steering group with involvement of stakeholders, users and carers. Together the steering group should:
• make sure they are clear about the aims of the service(s) to be evaluated;
• identify the aspects of quality to be explored in the evaluation; and
• identify the aims of the evaluation and/ or the questions to be answered by the evaluation. The steering group should also be consulted and involved in the following steps: 5) Consider adopting/adapting an evaluation framework. 6) Identify the specific objectives of your evaluation that will address the questions/aims, remain feasible and are within your resources. 7) Decide how each objective will be examined:
• consider which outcomes are relevant and feasible to examine; seek expert help where necessary.
8) Make sure that those commissioning the evaluations are happy with your aims, outcomes and design (if applicable). 9) Decide who will collect the data from the evaluation, when and how they will do this. 10) Decide who will manage the data after collection (eg, who will input the data? Who will clean it?). 11) Decide who will analyse the data from the evaluation, when and how they will do this. 12) Establish a time frame and set measurable milestones (eg, half the interviews will be completed by [date] , quantitative data will be analysed by [date]). 13) Get ethics committee approval (if applicable). 14) Cost your evaluation. 15) Collect and analyse the data. 16) Disseminate the findings.
As this article suggests, planning and conducting an evaluation of a complex intervention like a HaH/ED scheme may not be easy, especially in a local evaluation setting. However advance recognition of some of the potential pitfalls and complexities can only lead to improved evaluations and better interpretation of their findings.
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